本文旨在观察西妥昔单抗联合放疗对中国局部晚期头颈部鳞癌患者的近期疗效和安全性。
This paper aims to observe the short term efficiency and safety of Cetuximab combined with radiotherapy of head and neck squamous Cell carcinoma in Chinese patients.
本文旨在观察西妥昔单抗联合放疗对中国局部晚期头颈部鳞癌患者的近期疗效和安全性。
This paper aims to observe the short term efficiency and safety of Cetuximab combined with radiotherapy of head and neck squamous Cell carcinoma in Chinese patients.
应用推荐